Narayana Hrudayalaya Limited (NSE:NH)
1,916.90
-20.70 (-1.07%)
At close: Dec 5, 2025
Narayana Hrudayalaya Revenue
Narayana Hrudayalaya had revenue of 16.44B INR in the quarter ending September 30, 2025, with 17.41% growth. This brings the company's revenue in the last twelve months to 59.61B, up 14.18% year-over-year. In the fiscal year ending March 31, 2025, Narayana Hrudayalaya had annual revenue of 54.83B with 12.12% growth.
Revenue (ttm)
59.61B
Revenue Growth
+14.18%
P/S Ratio
6.53
Revenue / Employee
5.22M
Employees
11,411
Market Cap
389.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 54.83B | 5.93B | 12.12% |
| Mar 31, 2024 | 48.90B | 3.61B | 7.96% |
| Mar 31, 2023 | 45.30B | 8.28B | 22.38% |
| Mar 31, 2022 | 37.01B | 11.17B | 43.24% |
| Mar 31, 2021 | 25.84B | -5.53B | -17.62% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Divi's Laboratories | 100.29B |
| Cipla | 279.66B |
| Apollo Hospitals Enterprise | 232.65B |
| Zydus Lifesciences | 244.94B |
| Mankind Pharma | 135.46B |
| Aurobindo Pharma | 325.14B |
| Alkem Laboratories | 138.90B |
Narayana Hrudayalaya News
- 12 days ago - Stocks to buy: What's the outlook for Nifty for the week starting November 24? Check list of top stock recommendations - The Times of India
- 18 days ago - Narayana Hrudayalaya Ltd (BOM:539551) Q2 2026 Earnings Call Highlights: Robust Growth in Cayman ... - GuruFocus
- 18 days ago - Q2 2026 Narayana Hrudayalaya Ltd Earnings Call Transcript - GuruFocus
- 19 days ago - Narayana Hrudayalaya shares jump nearly 5% after Q2 profit up 30% - Business Upturn
- 22 days ago - What To Expect From Narayana Hrudayalaya Ltd (NSE:NH) Q2 2026 Earnings - GuruFocus
- 23 days ago - Narayana Hrudayalaya Ltd (NSE:NH) Q2 2026 Earnings Report Preview: What To Look For - GuruFocus
- 3 months ago - Narayana Hrudayalaya invests USD 2.5 million in Cayman Integrated Healthcare - Business Upturn
- 6 months ago - HSBC maintains reduce on Narayana Hrudayalaya, sees long gestation for India expansion - Business Upturn